Insider Buying: Assura Plc (LON:AGR) Insider Purchases 210 Shares of Stock
Assura Plc (LON:AGR – Get Rating) insider Jayne Cottam purchased 210 shares of Assura stock in a transaction on Monday, June 6th. The shares were acquired at an average price of GBX 71 ($0.89) per share, with a total value of £149.10 ($186.84).
Jayne Cottam also recently made the following trade(s):
- On Tuesday, May 31st, Jayne Cottam purchased 700 shares of Assura stock. The shares were acquired at an average price of GBX 71 ($0.89) per share, with a total value of £497 ($622.81).
- On Thursday, May 5th, Jayne Cottam purchased 228 shares of Assura stock. The shares were acquired at an average price of GBX 66 ($0.83) per share, with a total value of £150.48 ($188.57).
Shares of Assura stock opened at GBX 71.50 ($0.90) on Tuesday. The stock’s fifty day moving average is GBX 67.72 and its 200-day moving average is GBX 66.97. The firm has a market capitalization of £2.11 billion and a PE ratio of 12.71. The company has a quick ratio of 3.60, a current ratio of 4.64 and a debt-to-equity ratio of 69.84. Assura Plc has a 12-month low of GBX 59.28 ($0.74) and a 12-month high of GBX 80.60 ($1.01).
The business also recently announced a dividend, which will be paid on Wednesday, July 13th. Stockholders of record on Thursday, June 9th will be given a dividend of GBX 0.78 ($0.01) per share. The ex-dividend date of this dividend is Thursday, June 9th. This is a positive change from Assura’s previous dividend of $0.74. This represents a dividend yield of 1.14%. Assura’s payout ratio is 0.53%.
Nevada may be known as the “Silver State,” but it’s also the hot spot for North American lithium. With China controlling 80% of the world’s lithium supply, the defense industry and electric vehicle manufacturers are scrambling for more domestic sources of the valuable metal.
A number of research analysts have issued reports on AGR shares. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 79 ($0.99) price target on shares of Assura in a research report on Wednesday, May 25th. Peel Hunt restated an “add” rating and issued a GBX 85 ($1.07) price objective on shares of Assura in a report on Tuesday, May 24th. Shore Capital restated a “buy” rating on shares of Assura in a report on Tuesday, May 24th. Barclays restated an “overweight” rating and issued a GBX 80 ($1.00) price objective on shares of Assura in a report on Monday, May 23rd. Finally, Berenberg Bank restated a “hold” rating and issued a GBX 80 ($1.00) price objective on shares of Assura in a report on Tuesday, May 31st. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Assura currently has an average rating of “Buy” and an average target price of GBX 79.83 ($1.00).
Assura Company Profile (Get Rating)
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $1,000 in Assura right now?
Before you consider Assura, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Assura wasn’t on the list.
While Assura currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
